AdCEA 576-669 Hsp70L1-DCs induce CEA-specific CD8 + CTLs. a The expression of HLA-A11 on LoVo cells with and without β2m or/plus indicated nanopeptide (1 μg/ml) was detected using FACS. b, c Immature DCs, respectively, from HLA-A11 + , HLA-A2.1 + or HLA-A24 + healthy donors were pulsed with CEA 576-669 HSP70L1 (CH) or transfected with the indicated Ad for 48 h, and then restimulated with autogenous CD3 + T cells for a total of three cycles; then the frequencies of CD8 + T cells specifically recognizing epitopes of HLA-A11-resricted CEA 636-644 , HLA-A2-restricted CAP1 or HLA-A24-restricted CEA 652-660 were detected, respectively, using Pentamer staining and FACS analysis (b) or IFN-γ/ELISPOT (c), and the cytotoxicity by autogenous CD8 + T cells to LS-174T, SW480, SW620 or LoVo tumor cells labeled by CFSE was evaluated using cytotoxic assays and FACS analysis (d). Representative blots of IFN-γ/ELISPOT (c, left); HLA-24.2-restricted Her2 263-271 , HLA-A2.1-restricted Her2 435-443 , and HLA-A11.1-restricted EBV 416-424 were used as negative control in (c) (right three panels). All results are representative of three independent experiments. Values are % in FACS graphs (a, b, d) , and mean ± s.d. of three determinants (c, below). One-way ANOVA (c). **P < 0.01.
